Serum Institute of India to Launch Indigenously Made Vaccine to Treat Cervical Cancer

The Drugs Controller General of India (DCGI) on Tuesday granted market authorisation to Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer

from Top Business News- News18.com https://ift.tt/ko80PqX
via IFTTT